tRNA-derived fragments are altered in diabetes

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Maternally Inherited Diabetes and Deafness (MIDD) is a rare, adult-onset diabetes with a variable phenotype, making diagnosis challenging.
• Transfer RNA-derived small fragments (tiRNAs) are emerging non-coding RNAs with potential as serum biomarkers due to their stability and detectability.

Purpose of the Study:

• To investigate serum levels of tiRNA 5'ValCAC and miR-23b-3p in patients with MIDD, type 1 diabetes, and type 2 diabetes compared to healthy controls.
• To evaluate the diagnostic potential of these tiRNAs, individually and in combination, for differentiating MIDD from other diabetes types.

Main Methods:

• Small RNA sequencing was used to identify relevant tiRNAs.
• Serum samples from healthy controls, type 1 diabetes, type 2 diabetes, and MIDD subjects were analyzed for tiRNA 5'ValCAC and miR-23b-3p levels.
• Receiver Operating Characteristic (ROC) analysis was performed to assess biomarker potential.

Main Results:

• Serum levels of tiRNA 5'ValCAC were significantly reduced in MIDD and type 2 diabetes subjects compared to controls.
• Serum levels of miR-23b-3p were elevated in type 2 diabetes subjects compared to all other groups.
• The combination of 5'ValCAC and miR-23b-3p demonstrated excellent discriminatory power, particularly in separating MIDD from type 2 diabetes.

Conclusions:

• This study is the first to report altered serum tiRNA levels in diabetes patients.
• Combined measurement of serum 5'ValCAC and miR-23b-3p shows potential as a novel biomarker strategy for distinguishing MIDD from type 2 diabetes.